Skip to content

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05350007
Acronym
CANFRADE
Enrollment
180
Registered
2022-04-27
Start date
2022-05-25
Completion date
2022-12-31
Last updated
2022-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Death, Frailty, Rumination

Keywords

cancer, tanatophobia, rumination, fraility, elderly

Brief summary

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Detailed description

No studies were found in the literature evaluating the relationship between frailty and lack of social support with tanatophobia and rumination. The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Interventions

None listed

Sponsors

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum

Inclusion criteria

* 65 years or older * Conscious and no communication problems * Being literate * Willing to participate in our study voluntarily * Cancer patient receiving active chemotherapy treatment

Exclusion criteria

* Not being willing to participate in the research * Serious life-threatening condition (critical illness, intensive care unit stay, acute complication) * Dementia, Alzheimer's, cognitive dysfunction * Major psychiatric illness

Design outcomes

Primary

MeasureTime frameDescription
Rumination1 weekEvaluation of rumination in patients over 65 years of age receiving cancer chemotherapy
Tanatophobia1 weekEvaluation of tanatophobia in patients over 65 years of age receiving cancer chemotherapy

Secondary

MeasureTime frameDescription
fraility1 monthEvaluation of fraility in patients over 65 years of age receiving cancer chemotherapy
lack of social support1 monthEvaluation of lack of social support in patients over 65 years of age receiving cancer chemotherapy

Countries

Turkey (Türkiye)

Contacts

Primary ContactElif Yıldırım Ayaz, M.D.
drelifyildirim@hotmail.com+905325148300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026